Status:
COMPLETED
Increasing Vaccine Uptake in Underresourced Public Housing Areas
Lead Sponsor:
Charles Drew University of Medicine and Science
Conditions:
Coronavirus
Vaccine Refusal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This proposal seeks to enhance uptake and completion of COVID-19 vaccination among African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced...
Detailed Description
One particular group, African American and Latinx public housing residents, are facing adverse effects related to worsening social determinants and health disparities. Utilizing a community-driven app...
Eligibility Criteria
Inclusion
- Aim 2:
- identify as Latinx or African American
- age 18 or older
- reside in one of the six collaborating public housing area
- Speak either English or Spanish
Exclusion
- Not a resident at one of the collaborating public housing areas
- Does not self-identify as African American or Latinx
- Age 17 and younger
- Unable to speak either English or Spanish
- Aim 3:
- Inclusion Criteria:
- identify as Latinx or African American
- age 18 or older
- reside in one of the six collaborating public housing area
- Speak either English or Spanish
- Report vaccine hesitancy
Key Trial Info
Start Date :
September 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
462 Patients enrolled
Trial Details
Trial ID
NCT04779138
Start Date
September 11 2021
End Date
April 1 2024
Last Update
April 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles R. Drew University of Medicine & Science
Los Angeles, California, United States, 90059